Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10771800 | Biochemical and Biophysical Research Communications | 2005 | 6 Pages |
Abstract
Preferential expression of oncofetal extra domain-B fibronectin (EDB+ FN), a proposed angiogenic marker, has been shown in proliferative diabetic retinopathy. High levels of glucose also increase EDB+ FN expression in endothelial cells (ECs) via transforming growth factor-β1 (TGF-β1) and endothelin-1 (ET-1). The present study was aimed at elucidating the role of serum- and glucocorticoid-regulated kinase (SGK-1) in glucose-induced EDB+ FN expression. Using human macro- and microvascular ECs, we show that high levels of glucose, TGF-β1, and ET-1 increase the EDB+ FN expression via SGK-1 alteration at the mRNA, protein, and activity levels. Inhibition of TGF-β1 and ET-1 prevented glucose-induced SGK-1 activation and the EDB+ FN expression. Furthermore, using siRNA-mediated SGK-1 gene silencing, we show that glucose-induced EDB+ FN expression can be completely prevented. These findings provide first evidence of glucose-induced SGK-1 activation in altered EDB+ FN expression and provide novel avenues for therapeutic modalities.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Zia A. Khan, Yousef P. Barbin, Hana Farhangkhoee, Norbert Beier, Wolfgang Scholz, Subrata Chakrabarti,